Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients
Clinical trial NCT05463939 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05463939
- Sponsor
- Janssen Research & Development, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.